Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them…
Industry Peers
Drug Manufacturers - Specialty & Generic| Headline | Source | Time |
|---|---|---|
Today | ||
 3 Revenue Generating Psychedelics Stocks Retail Investors Are Screening Right Now Psychedelics stocks are becoming more popular as more research goes into them. Here are 3 stock ideas for your watchlist. | ||
This week | ||
 Optimi Health Establishes $100 Million Equity Facility as Psychedelic Commercialisation Advances Optimi Health has added financial flexibility to its growth strategy as it advances its MDMA and psilocybin business. | ||
Weekly Roundup on the Cannabis Sector & Psychedelic Sector Key Takeaways; Cannabis Sector Curaleaf Holdings Announced Intention to Launch a Hostile Takeover Bid to Acquire Aurora Cannabis Organigram Posted Record Quarter as Sanity Group Acquisition Fueled Global Expansion Key Takeaways; Psychedelic Sector Optimi Health Set Up US$100 Million Equity Facility to Support Growth Definium Therapeutics’ Phase 3 Trial Delivered Strong Results for DT120 in […] | MMarket Exclusive | |
Older | ||
Weekly Roundup on the Cannabis Sector & Psychedelic Sector Key Takeaways; Cannabis Sector Canopy Growth Posted 13% Revenue Growth as Losses Narrowed Sharply in Q1 FY2027 Aurora Cannabis Narrowed Q1 Loss as International Medical Cannabis Growth Gained Ground Cronos Group Reported Record Q2 Revenue as Profitability and EBITDA Surged Key Takeaways; Psychedelic Sector Compass Pathways is Building Momentum Toward Potential COMP360 Launch as Veterans […] | MMarket Exclusive | |
 3 Psychedelic Stocks With Potential Clinical Trial Catalysts Big pharma is funding a field it once dismissed. These three psychedelic stocks carry possible clinical catalysts as the healthcare industry turns to alternative medicines. | ||
Weekly Roundup on the Cannabis Sector & Psychedelic Sector Key Takeaways; Cannabis Sector Tilray Brands Expanded Medical Cannabis Platform with HelloMD Acquisition Vireo Growth Entered Pennsylvania with $20 Million Retail License Deal Key Takeaways; Psychedelic Sector Optimi Health Shipped Third Commercial Psilocybin Export to Australia Helus Pharma Reported Wider Fiscal Year 2026 Loss as Lead Depression Drug Advances Toward Phase 3 Readout Clearmind Medicine […] | MMarket Exclusive | |
 Why Optimi’s Ibogaine Initiative Could Open a New Growth Channel Optimi Health advances ibogaine strategy amid rising regulatory and research support. | ||
Optimi Health up 2.5% as It Completes Commercial 5mg Psilocybin Production Run Optimi Health (OPTI.CN), up 2.5% on last look, on Tuesday said it completed a production run of its | MMT Newswires | |
 SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public – Here’s What Aided The Decision SRx Health, which is merging with EMJ Crypto Technologies, said EMJ’s proprietary operating system used quantitative models and artificial intelligence to pick Optimi Health as an investment opportunity. | ||
Optimi Health Files LIFE Offering Document in Connection with NASDAQ Listing Optimi Health (OPTI.CN) plans to complete a portion of its previously announced offering of common s | MMT Newswires | |